[Federal Register Volume 59, Number 228 (Tuesday, November 29, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-29312]


[[Page Unknown]]

[Federal Register: November 29, 1994]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Public Health Service

 

National Institutes of Health; Statement of Organization, 
Functions, and Delegations of Authority

    Part H, Chapter HN (National Institutes of Health) of the Statement 
of Organization, Functions, and Delegations of Authority for the 
Department of Health and Human Services (40 FR 22859, May 27, 1975, as 
amended most recently at 59 FR 54000-02, October 27, 1994) is amended 
to reflect the reorganization of the National Institute on Drug Abuse. 
The reorganization consists of (1) retitling the Office of Science 
Policy, Education, and Legislation (HN614), and the Division of 
Clinical Research (HN62), and revising their functional statements; (2) 
retitling the Addiction Research Center (HN64); and (3) revising the 
functional statements of the Division of Epidemiology and Prevention 
Research (HN63), and the Division of Basic Research (HN65).
    Section HN-B, Organization and Functions is amended as follows: (1) 
Under the heading National Institute on Drug Abuse (HN6), Office of 
Science Policy, Education, and Legislation (HN614); and the Division of 
Clinical Research (HN62); delete the titles and functional statements 
in their entirety and substitute the following:
    Office of Science Policy and Communications (HN614). (1) Provides 
leadership and direction in planning, coordinating, analyzing, and 
evaluating the Institute's scientific research and research training 
programs; (2) represents the Institute's research and research training 
programs to other government agencies, the Congress, scientific and 
professional organizations, and the public; (3) evaluates, analyzes, 
and develops policy options in regard to the Institute's scientific 
research and research training activities; (4) prepares briefing 
materials and testimony for congressional hearings, and serves as 
liaison with the Congress, the White House, and other significant 
Federal and governmental agencies; (5) prepares reports, develops 
responses, and provides information on legislative efforts, responds to 
congressional inquiries, and analyzes legislative proposals for the 
Director; (6) advises the Director on national drug abuse policy 
issues; (7) conducts relevant public affairs, research dissemination, 
and application activities, deals with the press, media, and other 
communications organizations, and collaborates with a variety of public 
and private entities to enhance knowledge and awareness of NIDA's 
programs and findings; (8) provides liaison with scientific and 
professional groups and private organizations; and (9) plans, 
coordinates, analyzes, and evaluates the Institute's international 
program.
    Division of Clinical and Services Research (HN62). (1) Plans, 
stimulates, develops, and supports a broad extramural program of 
medical, etiological, and clinical neurobiological services and 
treatment research focusing on drug abuse; (2) supports studies 
designed to describe and address the problem of human medical 
conditions that may be associated with drug abuse; (3) supports 
research designed to develop and assess the efficacy of new and 
existing treatment techniques and treatment modalities; (4) supports 
research which focuses on developing and evaluating methodologies for 
recruiting drug abusers into treatment, retaining them, and preventing 
recidivism to drug use; (5) supports services research which focuses on 
the impact of alternative financing, organizational, and staffing 
patterns on the cost, quality, access, utilization, and outcome of drug 
abuse services; (6) supports research on the etiology and clinical 
neurobiology of drug abuse; and (7) supports research training in the 
clinical, psychological, and behavioral science and health services 
research disciplines in the field of drug abuse.
    (2) Under the heading Addiction Research Center (HN64), change the 
title to the Division of Intramural Research (HN64).
    (3) Under the heading Division of Epidemiology and Prevention 
Research (HN63), and the Division of Basic Research (HN65), delete the 
functional statements in their entirety and substitute the following:
    Division of Epidemiology and Prevention Research (HN63). (1) Plans, 
stimulates, develops, and supports a broad extramural program to study 
the nature, origins and vulnerability to, extent of, and patterns and 
consequences of drug use and abuse among general, special, community-
based, and subpopulations including consequences such as HIV infection; 
(2) plans, develops, and supports a broad-based extramural research 
program on prevention of drug use and abuse and associated conditions 
and early interventions and services research including the prevention 
of HIV and other medical/social/psychological sequelae of drug use and 
abuse; (3) supports a research program on innovative sampling, data 
collection, and analytic methodologies designed to support 
epidemiologic and prevention and early intervention and services 
research; (4) works cooperatively with Federal, State and local 
governmental agencies and international and private organizations to 
encourage sharing of drug use/abuse epidemiologic and prevention 
information, models, and research methodologies; (5) provides 
consultation and technical assistance, in the areas of theoretical 
models, research design, sampling, data collection, and statistical 
methods relative to the conduct of epidemiologic and prevention 
interventions and services research; and (6) develops training programs 
and supports individuals in the areas of drug use/abuse epidemiologic 
and prevention intervention and services research.
    Division of Basic Research (HN65). (1) Plans, develops, and 
administers an extramural program of biomedical, behavioral, and 
neuroscience research which seeks to develop new knowledge concerning 
the mechanisms and sites of action underlying drug abuse; (2) supports 
studies to develop new methodologies for testing the abuse potential of 
new compounds; (3) supports studies designed to determine the short- 
and long-term neurological, biological, and behavioral effects of drugs 
of abuse and those compounds which may be related to drugs of abuse; 
(4) supports research training to increase the skills, quantity, 
quality, and utilization of research investigators in the biomedical 
and behavioral disciplines in the drug abuse field; (5) supports 
studies designed to describe and understand drug abusing behavior and 
to ascertain the effects of drugs and environment on behaviors; (6) 
supports research into the synthesis of new compounds, new methods 
development, and drug metabolism; and (7) manages the distribution of 
controlled substances, research drugs, and chemicals.

    Dated: November 14, 1994.
Harold Varmus,
Director, NIH.
[FR Doc. 94-29312 Filed 11-28-94; 8:45 am]
BILLING CODE 4101-01-M